Contact us today for a complimentary consultation with a qualified attorney near you.
Trasylol, which is commonly administered to patients during heart surgery to control blood loss, has been shown to cause adverse, and even fatal side effects. A study released in January of 2006 in the New England Journal of Medicine highlighted the adverse Trasylol side effects that were previously unknown by health professionals and heart surgery patients. Trasylol side effects that were found evident in an alarming pattern among patients included a significantly increased risk of heart attacks, strokes, kidney failure, and heart failure.
The Study
The study performed to examine Trasylol side effects was pioneered by Dr. Dennis T. Mangano of the Ischemia Research and Education Foundation and involved a sampling of 4374 heart surgery patients. The patients consisted people who were administered Trasylol, those who took generic options and others who took nothing, during their cardiovascular procedure. The results were unsettling.
Trasylol Side Effects
Trasylol side effects pose and increased risk for heart attacks, strokes, kidney failure, and other serious cardiovascular complications. These side effects, in comparison with the generic options, resulted in a nearly doubled risk of renal failure, a 50 percent increased risk of heart attack and a 181 percent increased risk of stroke.
Trasylol makers, pharmaceutical company Bayer AG are challenging the findings claiming that they are inconsistent with fifteen years of thorough research conducted by the company. The results however, suggest that undetected side effects may in fact be due to insufficient trial periods.
Medication Alternatives
The results found in Dr. Mangano's study support the use of alternative options to avoid Trasylol side effects. Many doctors and medical professional involved in cardiovascular surgery admit to having been skeptical about Trasylol side effects far earlier than the release of the study. Effective alternatives for heart surgery blood clot medications are aminocaproic acid and tranexamic acid. In the research performed, aminocaproic acid and tranexamic acid proved to be just as effective, less costly, and significantly safer options than Trasylol.
Dr. Mangano has commented on his study, "In good conscious, I could not administer Trasylol to this group of patients, especially given the availability of safer alternatives. The least that should be done is to inform the patient that the risk of going on dialysis is increased 2 to 3 fold and there are alternatives."
If you or a loved on has been adversely affected by Trasylol side effects, you may be entitled to financial compensation for your pain and suffering. Contact us today to speak to an experienced personal injury attorney who is familiar with the legal rights of those injured by Trasylol. Our qualified attorneys can evaluate your case; free of charge and help you generate a plan to ensure that you rights are protected and your claims are maximized.
More Trasylol Resources